Skip to main content
. 2024 Mar 8;6(10):189–194. doi: 10.46234/ccdcw2024.038

Table 2. Association between HPV infection and other RTI pathogens infection among reproductive-age women in six tertiary hospitals in China from June 2021 to December 2022.

RTI pathogens Total HPV-positive HR-HPV- positive HPV 16/18-positive
n (%) Crude OR
(95% CI)
Adjusted OR
(95% CI)*
n (%) Crude OR
(95% CI)
Adjusted OR
(95% CI)*
n (%) Crude OR
(95% CI)
Adjusted OR
(95% CI)*
Abbreviation: HPV=human papillomavirus; HR-HPV=high risk HPV; RTI=reproductive tract infection; OR=odds ratio; CI=confidence interval.
* Adjusted for age group, ethnic group, education level, family monthly income, marital status, and parity.
† Regression was not possible because the sample size of the positive group was 0.
Neisseria gonorrhoeae
Negative 3,123 633 (20.3) Ref. Ref. 558 (17.9) Ref. Ref. 137 (4.4) Ref. Ref.
Positive 10 6 (60.0) 5.90 (1.66, 20.97) 10.82 (2.04, 57.4) 5 (50.0) 4.60 (1.33, 15.93) 6.86 (1.49, 31.72) 2 (20.0) 5.45 (1.15, 25.9) 9.31 (1.70, 51.08)
Chlamydia trachomatis
Negative 2,981 578 (19.4) Ref. Ref. 514 (17.2) Ref. Ref. 127 (4.3) Ref. Ref.
Positive 152 61 (40.1) 2.79 (1.99, 3.90) 2.64 (1.80, 3.86) 49 (32.2) 2.28 (1.60, 3.25) 2.18 (1.47, 3.24) 12 (7.9) 1.93 (1.04, 3.57) 2.14 (1.13, 4.05)
Ureaplasma species
Negative 1,813 268 (14.8) Ref. Ref. 241 (13.3) Ref. Ref. 60 (3.3) Ref. Ref.
Positive 1,320 371 (28.1) 2.25 (1.89, 2.69) 2.13 (1.75, 2.59) 322 (24.4) 2.10 (1.75, 2.53) 1.96 (1.60, 2.41) 79 (6.0) 1.86 (1.32, 2.62) 1.73 (1.18, 2.54)
Ureaplasma urealyticum
Negative 2,814 539 (19.2) Ref. Ref. 479 (17.0) Ref. Ref. 116 (4.1) Ref. Ref.
Positive 319 100 (31.3) 1.93 (1.49, 2.49) 1.97 (1.46, 2.65) 84 (26.3) 1.74 (1.33, 2.28) 1.67 (1.22, 2.29) 23 (7.2) 1.81 (1.14, 2.87) 1.59 (0.92, 2.72)
Ureaplasma parvum 1
Negative 2,964 591 (19.9) Ref. Ref. 519 (17.5) Ref. Ref. 130 (4.4) Ref. Ref.
Positive 169 48 (28.4) 1.59 (1.13, 2.25) 1.45 (1.00, 2.12) 44 (26.0) 1.66 (1.16, 2.37) 1.58 (1.07, 2.32) 9 (5.3) 1.23 (0.61, 2.45) 1.01 (0.46, 2.24)
Ureaplasma parvum 3
Negative 2,577 497 (19.3) Ref. Ref. 442 (17.2) Ref. Ref. 108 (4.2) Ref. Ref.
Positive 556 142 (25.5) 1.44 (1.16, 1.78) 1.36 (1.07, 1.73) 121 (21.8) 1.34 (1.07, 1.68) 1.23 (0.95, 1.58) 31 (5.6) 1.35 (0.90, 2.03) 1.16 (0.73, 1.85)
Ureaplasma parvum 6
Negative 2,709 502 (18.5) Ref. Ref. 441 (16.3) Ref. Ref. 109 (4.0) Ref. Ref.
Positive 424 137 (32.3) 2.10 (1.68, 2.63) 1.93 (1.51, 2.48) 122 (28.8) 2.08 (1.64, 2.62) 1.97 (1.52, 2.54) 30 (7.1) 1.82 (1.20, 2.76) 1.76 (1.12, 2.78)
Ureaplasma parvum 14
Negative 3,122 635 (20.3) Ref. Ref. 560 (17.9) Ref. Ref. 139 (4.5)
Positive 11 4 (36.4) 2.24 (0.65, 7.67) 2.86 (0.80, 10.3) 3 (27.3) 1.72 (0.45, 6.49) 2.22 (0.57, 8.69) 0 (0) –† –†
Mycoplasma genitalium
Negative 3,112 627 (20.1) Ref. Ref. 552 (17.7) Ref. Ref. 135 (4.3) Ref. Ref.
Positive 21 12 (57.1) 5.28 (2.22, 12.6) 3.17 (1.22, 8.22) 11 (52.4) 5.1 (2.16, 12.07) 3.06 (1.17, 7.99) 4 (19.0) 5.19 (1.72, 15.63) 6.09 (1.91, 19.49)
Mycoplasma hominis
Negative 2,986 577 (19.3) Ref. Ref. 509 (17.0) Ref. Ref. 126 (4.2) Ref. Ref.
Positive 147 62 (42.2) 3.05 (2.17, 4.28) 2.76 (1.87, 4.08) 54 (36.7) 2.83 (1.99, 4.00) 2.48 (1.66, 3.71) 13 (8.8) 2.20 (1.21, 4.00) 2.23 (1.15, 4.30)
Herpes simple virus type Ⅱ
Negative 3,106 621 (20.0) Ref. Ref. 545 (17.5) Ref. Ref. 136 (4.4) Ref. Ref.
Positive 27 18 (66.7) 8.00 (3.58, 17.90) 6.67 (2.89, 15.36) 18 (66.7) 9.40 (4.20, 21.03) 7.94 (3.44, 18.29) 3 (11.1) 2.73 (0.81, 9.18) 2.38 (0.69, 8.25)
Any RTIs
Negative 1,691 226 (13.4) Ref. Ref. 206 (12.2) Ref. Ref. 46 (2.7) Ref. Ref.
Single-RTI-positive 1,125 273 (24.3) 2.08 (1.71, 2.53) 1.97 (1.59, 2.45) 235 (20.9) 1.90 (1.55, 2.34) 1.82 (1.45, 2.28) 63 (5.6) 2.12 (1.44, 3.13) 2.17 (1.41, 3.34)
Multiple-RTI-positive 317 140 (44.2) 5.13 (3.94, 6.66) 4.85 (3.59, 6.56) 122 (38.5) 4.51 (3.45, 5.90) 4.17 (3.06, 5.68) 30 (9.5) 3.74 (2.32, 6.02) 3.47 (2.01, 6.00)